| Product Code: ETC5311256 | Publication Date: Nov 2023 | Updated Date: Nov 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Ravi Bhandari | No. of Pages: 60 | No. of Figures: 30 | No. of Tables: 5 |
The import shipments of pulmonary/respiratory drug delivery products to Fiji in 2024 continued to be dominated by top exporting countries such as Australia, New Zealand, India, Bangladesh, and the USA. Despite a slight decline in growth rate from 2023 to 2024, the industry maintained a healthy Compound Annual Growth Rate (CAGR) of 6.89% over the period of 2020-2024. The high Herfindahl-Hirschman Index (HHI) indicates a concentrated market in 2024, suggesting a stable competitive landscape within the pulmonary drug delivery sector in Fiji.

1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Fiji Pulmonary/ Respiratory Drug Delivery Market Overview |
3.1 Fiji Country Macro Economic Indicators |
3.2 Fiji Pulmonary/ Respiratory Drug Delivery Market Revenues & Volume, 2021 & 2031F |
3.3 Fiji Pulmonary/ Respiratory Drug Delivery Market - Industry Life Cycle |
3.4 Fiji Pulmonary/ Respiratory Drug Delivery Market - Porter's Five Forces |
3.5 Fiji Pulmonary/ Respiratory Drug Delivery Market Revenues & Volume Share, By Formulations, 2021 & 2031F |
3.6 Fiji Pulmonary/ Respiratory Drug Delivery Market Revenues & Volume Share, By Canister Type, 2021 & 2031F |
3.7 Fiji Pulmonary/ Respiratory Drug Delivery Market Revenues & Volume Share, By Applications, 2021 & 2031F |
3.8 Fiji Pulmonary/ Respiratory Drug Delivery Market Revenues & Volume Share, By End User, 2021 & 2031F |
4 Fiji Pulmonary/ Respiratory Drug Delivery Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of respiratory diseases in Fiji |
4.2.2 Growing awareness about the importance of pulmonary drug delivery |
4.2.3 Technological advancements in respiratory drug delivery devices |
4.3 Market Restraints |
4.3.1 Limited access to healthcare facilities in remote areas of Fiji |
4.3.2 High cost associated with pulmonary drug delivery devices |
4.3.3 Lack of skilled healthcare professionals specialized in respiratory care |
5 Fiji Pulmonary/ Respiratory Drug Delivery Market Trends |
6 Fiji Pulmonary/ Respiratory Drug Delivery Market Segmentations |
6.1 Fiji Pulmonary/ Respiratory Drug Delivery Market, By Formulations |
6.1.1 Overview and Analysis |
6.1.2 Fiji Pulmonary/ Respiratory Drug Delivery Market Revenues & Volume, By Type, 2021-2031F |
6.1.3 Fiji Pulmonary/ Respiratory Drug Delivery Market Revenues & Volume, By Device Type, 2021-2031F |
6.2 Fiji Pulmonary/ Respiratory Drug Delivery Market, By Canister Type |
6.2.1 Overview and Analysis |
6.2.2 Fiji Pulmonary/ Respiratory Drug Delivery Market Revenues & Volume, By Plain Canister, 2021-2031F |
6.2.3 Fiji Pulmonary/ Respiratory Drug Delivery Market Revenues & Volume, By Coated Canister, 2021-2031F |
6.3 Fiji Pulmonary/ Respiratory Drug Delivery Market, By Applications |
6.3.1 Overview and Analysis |
6.3.2 Fiji Pulmonary/ Respiratory Drug Delivery Market Revenues & Volume, By Asthma, 2021-2031F |
6.3.3 Fiji Pulmonary/ Respiratory Drug Delivery Market Revenues & Volume, By COPD, 2021-2031F |
6.3.4 Fiji Pulmonary/ Respiratory Drug Delivery Market Revenues & Volume, By Cystic Fibrosis, 2021-2031F |
6.4 Fiji Pulmonary/ Respiratory Drug Delivery Market, By End User |
6.4.1 Overview and Analysis |
6.4.2 Fiji Pulmonary/ Respiratory Drug Delivery Market Revenues & Volume, By Hospitals & Clinics, 2021-2031F |
6.4.3 Fiji Pulmonary/ Respiratory Drug Delivery Market Revenues & Volume, By Homecare settings, 2021-2031F |
7 Fiji Pulmonary/ Respiratory Drug Delivery Market Import-Export Trade Statistics |
7.1 Fiji Pulmonary/ Respiratory Drug Delivery Market Export to Major Countries |
7.2 Fiji Pulmonary/ Respiratory Drug Delivery Market Imports from Major Countries |
8 Fiji Pulmonary/ Respiratory Drug Delivery Market Key Performance Indicators |
8.1 Average number of respiratory disease cases diagnosed annually in Fiji |
8.2 Adoption rate of pulmonary drug delivery devices in healthcare facilities |
8.3 Percentage of healthcare providers trained in respiratory care practices |
9 Fiji Pulmonary/ Respiratory Drug Delivery Market - Opportunity Assessment |
9.1 Fiji Pulmonary/ Respiratory Drug Delivery Market Opportunity Assessment, By Formulations, 2021 & 2031F |
9.2 Fiji Pulmonary/ Respiratory Drug Delivery Market Opportunity Assessment, By Canister Type, 2021 & 2031F |
9.3 Fiji Pulmonary/ Respiratory Drug Delivery Market Opportunity Assessment, By Applications, 2021 & 2031F |
9.4 Fiji Pulmonary/ Respiratory Drug Delivery Market Opportunity Assessment, By End User, 2021 & 2031F |
10 Fiji Pulmonary/ Respiratory Drug Delivery Market - Competitive Landscape |
10.1 Fiji Pulmonary/ Respiratory Drug Delivery Market Revenue Share, By Companies, 2024 |
10.2 Fiji Pulmonary/ Respiratory Drug Delivery Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations | 13 Disclaimer |